
==== Front
Jpn J Ophthalmol
Jpn J Ophthalmol
Japanese Journal of Ophthalmology
0021-5155
1613-2246
Springer Japan Tokyo

39271608
1109
10.1007/s10384-024-01109-8
Forefront Review
Ocular genetics in the Japanese population
http://orcid.org/0000-0003-4052-5066
Hotta Yoshihiro yoshotta@gmail.com

Torii Kaoruko
Takayama Masakazu
https://ror.org/00ndx3g44 grid.505613.4 0000 0000 8937 6696 Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu city, Shizuoka, 431-3192 Japan
14 9 2024
14 9 2024
2024
68 5 401418
9 4 2024
3 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
In today’s globalized society, ophthalmologists can examine people of different ethnicities regardless of where they live. The frequency of disease-causing genes varies according to a patient’s ethnic background. We explain genetic findings for Japanese patients with inherited eye diseases. Ocular genetics has made great advances over the past 30 years. For example, detecting mutations at nucleotide position 11778 in mitochondrial DNA was useful in the genetic diagnosis of Leber’s hereditary optic neuropathy (LHON). I evaluated the genotype-phenotype relationship in cases of corneal dystrophy and inherited retinal dystrophy (IRD). I identified the entire exon sequence of the eyes shut homolog (EYS) gene in patients with autosomal recessive retinitis pigmentosa (RP). EYS gene mutations are the most frequent cause of autosomal recessive RP. RPGRIP1 may be a common causative gene with early-onset severe retinal dystrophy, including Leber congenital amaurosis. However, some genes have complex structures that are difficult to analyze, including the OPN1LW/OPN1MW gene cluster in blue cone monochromacy and the IKBKG/NEMO genes in incontinentia pigmenti. This review will also present two cases with uniparental disomy, a case of IRD with double mutations, and a case with RP complicated with LHON-like neuropathy. Precise understanding of the effects of genetic variants may reveal differences in the clinical characteristics of patients with the same variant. When starting genome medicine, accurately diagnosing the patient, making accurate prediction, determining the genetic pattern, and providing genetic counseling are important. Above all, that both the doctors and patients understand genetic diseases correctly is important.

Keywords

Hereditary eye disease
Inherited retinal dystrophy
Retinitis pigmentosa
Early-onset severe retinal dystrophy (EOSRD)
Genetic counseling
http://dx.doi.org/10.13039/501100001691 Japan Society for the Promotion of Science JP20K09825 23K09041 Hotta Yoshihiro Torii Kaoruko http://dx.doi.org/10.13039/100009619 Japan Agency for Medical Research and Development JP23ek0109549 Hotta Yoshihiro http://dx.doi.org/10.13039/501100003478 Ministry of Health, Labour and Welfare 23FC1055 Hotta Yoshihiro issue-copyright-statement© Japanese Ophthalmological Society 2024
==== Body
pmcIntroduction

As people travel more easily and the world becomes more globalized, ophthalmologists can see patients of different ethnicities regardless of location. Inherited eye diseases (IRDs), of which retinitis pigmentosa (RP) is typical, have poor prognoses. Few curative treatments are available other than treatment for complications such as cataracts. Therefore, accurately diagnosing the patient, making the most accurate prediction, determining the inheritance pattern, and providing genetic counseling are important. The extent and significance of genetic contributions to eye disease depend on the disease. RP and color vision defects are caused primarily by genetic abnormalities; age-related macular degeneration and moderate myopia are caused by several genetic predispositions as well as other factors.

Molecular genetics has progressed remarkably in the last three decades. DNA was once amplified using E. coli, but DNA is now amplified using the polymerase chain reaction (PCR). DNA sequencing, which involves analyzing and determining nucleotide fragments, has advanced significantly since the time DNA fragments had to be cloned before being sequenced. The sequence of the entire human genome was roughly determined in AD 2000, so the rapid progress is surprising. The invention of next-generation sequencing allows genome decoding to be outsourced; current databases contain many genome sequences. Here, we review the status of genetic findings to assist the genetic counseling for Japanese patients with inherited eye diseases. Some dates may be out of order, depending on the structure of the content.

Leber’s hereditary optic neuropathy (LHON)

In 1988, a group at Emory University reported the 11778 mitochondrial gene mutation in LHON (OMIM 535000) [1]. In 1989, a follow-up study was reported from Japan [2]. In the same year, we reported for the first time that genetic analysis using PCR and the restriction enzyme SfaNI was useful for diagnosis [3]. Although the prognosis of LHON caused by the 11778 mutation is poor, we experienced a case in which the visual acuity in one eye was restored [4].

Deciphering the high complication rate of the 11778 mutation in patients with LHON was a breakthrough; consequently, mitochondrial gene analyses of patients with LHON in Japan have been performed [5]. To clarify the status of patients in Japan, we conducted a multicenter survey using a questionnaire. We obtained responses from 64 (74.4%) of 86 universities with medical schools in Japan. Although the visual prognosis of LHON complicated by the 11778 mutation is poor, the visual prognosis of this cohort is slightly better than that reported for the USA [6, 7].

Corneal dystrophy

In 1997, a group at the University of Lausanne reported TGFBI gene abnormalities in corneal dystrophy (OMIM 601692) [8]. Following that report, we investigated corneal dystrophy cases at Juntendo University and Nagoya University by the Sanger method. We found that variants of the TGFBI gene caused many corneal dystrophies, and the genotype correlated strongly with the phenotype [9–20]. Corneal dystrophies caused by the heterozygous R124H variant often do not cause severe visual dysfunction in adults, but homozygous cases cause visual impairment problems from childhood (Fig. 1) [10]. Lattice corneal dystrophy caused by the heterozygous L527R of the TGFBI gene is characterized by thick lattice changes and left–right differences [11, 20, 21]. Although the heterozygous variant of L527R is not clinically problematic until an advanced age, Figure 1 shows an older patient whose eye exhibited intense corneal findings with repeated corneal erosions that caused visual impairment.Fig 1. Corneal dystrophy caused by TGFBI gene mutations. a Lattice corneal dystrophy due to heterozygous R124C mutation (age 57) [21]. A thin grid-like opacity is observed. b Avellino corneal dystrophy due to homozygous R124H mutations (age 14) [10]. c Right eye and d left eye of an 82-year-old patient with lattice corneal dystrophy due to a heterozygous L527R mutation [19]

Fundus albipunctatus

In 1999, a group at the Massachusetts Eye and Ear Infirmary reported RDH5 gene abnormalities in fundus albipunctatus (OMIM #136880) [22]. In 2000, we examined the RDH5 gene in 14 patients (12 families) with fundus albipunctatus (OMIM 136880) at Nagoya University. Six patients (six families) had concomitant cone dystrophy. All patients had RDH5 mutations; those with cone dystrophy were older (48–74 years old). Therefore, we speculated that fundus albipunctatus is complicated by cone dysfunction in older age [23]. We also identified a high-frequency Japanese mutation, c.928delinsGAAG (p.L310delinsEV) (Table 1). We also examined the RDH5 and RS1 genes in three patients (three families) diagnosed with juvenile retinoschisis (OMIM 312700). The diagnosis was based on several findings, such as electroretinography (ERG), but additional complications occurred due to fundus albipunctatus-like findings. All the patients were diagnosed during childhood, showing pseudo–macular edema and spoke-like appearance in both eyes. The RDH5 gene mutation was not detected in the three patients; they all had hemizygous mutations in the RS1 gene [24]. Therefore, we consider that the albipunctatus-like findings in these patients indicate juvenile retinoschisis. The albipunctatus-like findings are also associated with RLBP1 and RPE65 variants [25–29].Table 1. Variants frequently detected in Japanese patients with hereditary eye diseases

Gene	Variant	Allele Frequency	
	Nucleotide change	Protein change	ToMMo 54KJPN	gnomAD v4.1.0	
East Asian	European	Global	
EYS(NM_001142800.2)	c.4957dup	p.S1653Kfs*2	0.004001	0.001981	0	0.000052	
	c.8805C>A	p.Y2935*	0.001974	0.001588	0	0.000043	
	c.6557G>A	p.G2186E	0.000627	0.000543	0.000001	0.000015	
	c.2528G>A	p.G843E	0.018548	0.009317	0	0.000247	
PDE6B(NM_000283.4)	c.1604T>A	p.I535N	0.000893	0.000223	0	0.000006	
	c.1669C>T	p.H557Y	0.000322	0.000509	0	0.000014	
TACSTD2(NM_002353.3)	c.352C>T	p.Q118*	0.000700	0.000157	0	0.000004	
RDH5(NM_002905.5)	c.928delinsGAAG	p.L310delinsEV	NA	NA	NA	NA	
USH2A(NM_206933.4)	c.2802T>G	p.C934W	0.002155	0.002564	0.000004	0.000090	
	c.8254G>A	p.G2752R	0.000332	0.000334	0.000006	0.000015	
	c.8559-2A>G	p.?	0.000111	0.000335	0	0.000010	
	c.10859T>C	p.I3620T	0.000773	0.000490	0.000001	0.000015	
54KJPN: Allele frequency data of SNV/INDEL from short-read whole genome sequencing of 54000 Japanese individuals (https://jmorp.megabank.tohoku.ac.jp/)

gnomAD v4.1.0 (https://gnomad.broadinstitute.org/)

NA not applicable

Retinitis pigmentosa (RP)

RP is the most serious ocular disease, with a frequency of 1 in 3000 to 5000, making it one of the most frequent genetic diseases [30]. Unlike glaucoma, RP has few effective treatments. The clinical presentation is diverse, ranging from patients who are nearly blind at age 20 to those who retain central vision even in old age. This issue is a serious problem in ophthalmology in our aging society. In 1990, the same Massachusetts Eye and Ear Infirmary group reported a mutation in the RP rhodopsin gene [31]. We examined codon 23 and codon 347 of the rhodopsin gene in 19 families with RP considered to have a dominant inheritance pattern at Tohoku University and Juntendo University. A missense mutation of the rhodopsin gene, P347L, was found in one family from Tohoku University. This case was the first report of a variant in RP in Japan [32]. We also identified two families of sectorial RP caused by variants N15S and T17M of the rhodopsin gene [33, 34]. A recent study using a genetic test panel reports that the prevalence of rhodopsin variants in Japanese patients with RP was approximately 2%; R347L was the most commonly detected [35].

The eyes shut homolog (EYS) gene is one of the major genes associated with autosomal recessive RP [36–38]. We extracted genomic DNA from the peripheral blood of 100 patients with RP, excluding cases with obvious autosomal dominant inheritance, analyzing exons 1–44 of the EYS gene by PCR direct sequencing. The EYS gene is a large (2 Mb) gene important for the morphogenesis of the Drosophila compound eye. We identified seven variants of the EYS gene in 18 of the 100 patients. We identified a frameshift mutation (c.4957dupA, due to an insertion) in 12 of the 18 patients and a nonsense mutation (c.8805C>A, p.Y2935X) in 4 of the patients. These two variants are the most frequent gene mutations in Japanese patients with RP. These results were reported by two institutions simultaneously [39, 40]. We focused on the two prominent variants and screened 32 Korean patients with autosomal recessive RP. All 32 Korean patients were from Gyeongsangbuk-do. We identified frameshift mutations due to insertions in two of the 32 patients and C-to-A nonsense mutations in one of them. We screened 19 Japanese patients with autosomal dominant and 28 with Leber congenital amaurosis (LCA) for the two mutations above, but the two mutations were not found in this cohort. Increasing utilization of next-generation sequencing technology in genetic analysis has enabled extensive studies on different retinal dystrophies in Japan [41–43]. Large-scale analysis by whole-exome sequencing (WES) showed that the EYS gene aberrations are predominant in retinal dystrophies in Japan, including RP (Table 1) [44]. When Japanese parents who are both suffering from RP consider having children, the probability that the offspring will be homozygous or compound heterozygous for the EYS variant cannot be ignored.

When gene variants are common, determining whether the variant is the cause of a disease is challenging; this is known as the variant of unknown significance. The EYS gene variant G843E has a very high allelic frequency as a possible cause of diseases showing Mendelian inheritance. In 2012, we could not determine whether this allele is pathogenic because of its extremely high allelic frequency and the lack of homozygous patients in our cohort; however, EYS variants in RP have been reported, including this variant [45–48]. This allele is also reported to cause EYS dysfunction, mildly affecting the phenotype. It may coexist in a patient heterozygous for the c.5797C>T, p(R1933X) variant of the RP1 gene and G843E EYS allele. Both reports propose a novel non-Mendelian inheritance [49, 50]. We anticipate further progress in research in this direction and advances in gene analysis techniques, including long-range PCR, functional analysis to confirm the effects of gene mutations, and gene editing [48, 51].

Usher syndrome is caused by a USH2A genetic abnormality (OMIM 608400) and will be discussed later. RP caused by variants of USH2A (nonsyndromic) is common in Europe and the United States of America (USA); a detailed clinical description has been reported [52, 53]. Among the RP cohort described in the previous paragraphs, we analyzed 82 cases by PCR direct sequencing of exons 1–73 of the USH2A gene, excluding 18 cases with an EYS mutation. In 3 of the 82 cases, a variant was identified as the possible cause of the disease; the variant differs from the spectrum of mutations in Europe and the USA [54]. Among these patients, one with RP15H exhibited homozygosity for the USH2A gene variant highly prevalent in Japan and was diagnosed with Usher syndrome based on abnormal hearing test results. Despite a follow-up period of >10 years for the patient with RP15H, hearing loss was identified only after a genetic analysis. In our initial cohort, we frequently observed that individuals retain their vision until they reach 30 years of age. However, we cannot assert this finding definitively because of the low number of patients. In addition, visual field narrowing is considerably advanced in patients in their 30 s [55]. As the number of cases increases, genetic diagnoses are anticipated to prove valuable to clinicians for determining prognoses.

Next-generation sequencers can identify the causative genes in 30–40% of patients with RP [41–43]; however, the challenge lies in the failure to detect these genes in the remaining patients. EYS, USH2A, and RP1 (which also cause autosomal dominant RP) are the most common causative genes for autosomal recessive RP. Rhodopsin and PRPF31 are causative genes for autosomal dominant RP. RPGR causes X-linked RP (XLRP). Once the causative gene is determined, predicting the inheritance pattern is often possible, even in sporadic cases. However, genetic penetrance and complicated inheritance, such as pseudo-dominant inheritance and isodisomy, present challenges.

Early onset severe retinal dystrophy (EOSRD)

Pediatric IRDs includes many diseases ranging from relatively mild to severe visual impairment. They also include cases with one of the symptoms of a systemic syndrome. Pediatric IRDs are less common than RP. LCA (MIM 204000) is rare and the most serious IRD. LCA is a genetically and clinically heterogeneous disease. The diagnosis of LCA is sometimes confusing and diagnosed as early-onset severe retinal dystrophy (EOSRD). We previously conducted a target sequencing study of 34 families with LCA at the National Center for Child Health and Development (NCCHD), Hamamatsu University School of Medicine, The Jikei University School of Medicine, and the University of Occupational and Environmental Health. However, this cohort is not consecutive and has a bias in specimen collection. All patients met the following criteria: (1) severe visual impairment (e.g., nyctalopia, nystagmus, very poor or absent ocular pursuit, or oculodigital sign) within the first year after birth; (2) a severely reduced or non-detectable ERG; and (3) no systemic abnormality other than neurodevelopmental delay at the time of examination. Most of the causative genes accounted for only a single pedigree, except CRB1 (three families), NMNAT1 (three families), RPGRIP1 (three families), and GUCY2D (two families) [56–58].

We recently performed WES and whole-genome sequencing (WGS) on newly recruited cases with the above-mentioned criteria and unresolved cases from a previous study [59]. We identified LCA caused by RPGRIP1 variants in five cases from four families. In particular, a 1339 bp deletion encompassing exon 18 of RPGRIP1 was observed in three individuals from two families (Fig. 2). Consistent with a previous report, an exon 18 deletion in RPGRIP1 was detected in six individuals from four families in Japan [56, 60]. An exon 18 deletion was also identified in a recently published database of Japanese cohorts. Because the allele frequency is relatively high at 0.002, this variant should be considered in genetic counseling for LCA/EOSRD. Although we analyzed a few patients, we believe RPGRIP1 may be a common causative gene in Japanese patients with LCA/EOSRD.Fig 2. Pedigrees and schematic representation of RPGRIP1 variants. a Pedigree of five patients with biallelic RPGRIP1 variants. The segregation of each variant is shown. b Schematic representation of the RPGRIP1 transcript (NM_020366.4) (b). The untranslated and coding regions are represented by open and filled rectangles, respectively. The baits of Agilent SureSelect V6 are shown in gray boxes. RPGRIP1 variants of five patients diagnosed using whole-genome sequencing are shown together with those of five patients from our previous report [59]

Although making a simple comparison is difficult, a recent analysis of retinal dystrophies in a group of 411 family members under 18 years of age in the United Kingdom showed a prominent aberration of the ABCA4 gene [61]. However, in our cohort, ABCA4 gene abnormalities were found in only two families. These reports suggest that the frequency of the causative genes varies according to a patient’s ethnic background. Because of the limited number of cases, conducting additional research is imperative.

Complex genes

(1) Blue cone monochromacy (BCM)

Blue cone monochromacy (BCM, OMIM 303700) is a rare, X-linked genetic disorder associated with severe visual impairment. The OPN1LW/OPN1MW cluster on the long arm of the X chromosome (Xq28) encodes long-wave–sensitive and medium-wave–sensitive opsins. BCM is caused by an abnormality in the OPN1LW/OPN1MW gene cluster. We performed molecular genetic analysis of two families examined at Nagoya University (families N and W) [62, 63]. The OPN1LW/OPN1MW cluster consists of one OPN1LW gene and several OPN1MW genes in tandem. Since the sequences of the OPN1LW gene and the OPN1LW base sequence are almost identical, the analysis of the OPN1LW gene requires a certain level of ingenuity. The deletion in the W family shown in Fig 3a was relatively easy to identify, attributed to its extension from the promoter to the OPN1LW gene; the presence of a repetitive DNA sequence (AluSz) upstream of the deletion breakpoint was confirmed. In the N family shown in Fig 3b, a long region including at least the entire exon of the OPN1LW gene was deleted from 2.8 kb upstream of the gene to a breakpoint around 7.7 kb downstream of the gene. Between the two deletions, 328 bp of the deleted sequence was inverted, and three additional unknown bases were inserted. In addition to the deletions, partial duplication or non-homologous recombination occurred between OPN1LW and OPN1MW1. OPN1MW2 may have caused the formation of hybrid genes; the exact genome structure could not be determined. Figure 3b shows an example of the putative genome structure of the N family. In common with the W and N families, the upstream, downstream, and inverted sequences of the deletion breakpoints contained high-frequency DNA repeats.Fig 3. Determination deletion breakpoints in two Japanese families with blue cone monochromacy (BCM). a Analysis of the deletion–insertion mutation by junction PCR and sequencing in Case BCM1 (W family). Genomic structure of human OPN1LW. The red and black boxes represent the OPN1LW exons and locus control region (LCR), respectively. Case BCM1 has a 16,856-bp deletion and 53-bp insertion. The proximal and distal boundaries of the deletion are 8899 bp upstream of the OPN1LW translational start codon and within OPN1LW intron 2, respectively. The proximal boundary of the breakpoint is an AluSz repeat sequence; the 53-bp insertion contains a partial Alu repeat sequence. b Analysis of the deletion–inversion–insertion mutation by genomic walking in Case BCM2 (N family). Genomic structure of human OPN1LW and OPN1MW genes. The red and green boxes represent the OPN1LW and OPN1MW exons, respectively; the black box represents the LCR. Case BCM2 has an 87,682-bp deletion, an inverted 328-bp re-insertion that is a part of the deleted sequence, and a 3-bp insertion. The proximal and distal boundaries of the deletion are 28,144 bp upstream of the OPN1LW start codon and 7764 bp downstream of the OPN1MW1 translation stop codon, respectively. In Case BCM2, exons 2 and 4 of OPN1LW are absent, whereas the presence of exon 5 in OPN1LW and OPN1MW2 are confirmed. Case BCM2 may harbor a normal OPN1MW2 gene and a hybrid gene comprising OPN1MW2 exons 1–4 joined to OPN1LW exons 5 and 6. The brackets indicate that this structure is possible, including the order of the hybrid gene and OPN1MW2. c Diagram and electropherogram of the region surrounding the deletion–inversion–insertion breakpoints in Case BCM2, located within highly repetitive sequences [63]

BCM is characterized by abnormalities in the OPN1LW/OPN1MW cluster and has a highly intricate cause, as indicated by the following findings: (1) major deletions and structural variations in the same gene cluster, (2) point mutations causing single or multiple loss of function in the same gene cluster, and (3) rare exon 3 haplotypes that cause splicing abnormalities in single or multiple copies of the gene [63–68]. The structure of the gene cluster complicates genetic diagnosis by PCR or next-generation sequencing. An ERG is more clinically useful than a genetic diagnosis since it can be diagnosed by ERG (RETevalTM), which has recently become available [69].

(2) Incontinentia pigmenti with retinopathy

Incontinentia pigmenti (OMIM 308300) is an infantile disorder having rashes and ocular and central nervous system manifestations, with retinopathy in approximately 35% of cases [70]. It affects mainly females; male patients are rare. It is caused by a variant of the IKBKG/NEMO gene. With an X-linked dominant mode of inheritance, deletions of exons 4–10 in the IKBKG/NEMO gene are found in approximately 80% of affected individuals [71]. Male patients are reported to have somatic cell mosaicism [72]. Molecular genetic analyses of patients with retinopathy at the NCCHD, whose diagnoses were confirmed by skin biopsy, were conducted in cooperation with the Preeminent Medical Photonics Education & Research Center (Table 2). The causative gene for incontinentia pigmenti, IKBKG/NEMO, has a complex structure and includes pseudogenes (Fig. 4). Four patients, including a boy, showed a deletion of exons 4–10 in the known IKBKG/NEMO gene; subsequently, we identified a truncation of the deletion [73]. The deletion of P295 was de novo; the deletion of P356 was of maternal origin. Extensive sequencing of the exons and surrounding regions of P280 did not reveal any causative variants. No deletion variants were detected in the blood DNA of the male patients, but saliva DNA showed a mosaic pattern with a mixture of both deleted and undeleted IKBKG/NEMO genes (in approximately equal amounts in the samples collected at the time of the study). No deletion variants were detected in vital tissues, suggesting that IKBKG/NEMO is normal and explaining how the male patient is alive. More cases need to be documented to examine changes over time.Table 2 Molecular genetic analysis of incontinentia pigmenti with retinopathy

Patient	Gender	Age	Family history	Ocular findings	Systemic findings other than skin	IKBKG/NEMO gene variants	Remarks	
P262	Male	4 months	None	Retinopathy (OU)	malformed teeth	Exon 4–10 deletion	A mosaicism*	
P280	Female	11 months	Mother with retinopathy	Retinopathy (OU)	malformed teeth	Not detected		
P295	Female	5 years	None	Retinopathy (OU)	malformed teeth	Exon 4-10 delation(de novo)		
P301	Female	5 years	None	Retinopathy(OS)	None	Exon 4-10 delation		
P356	Female	3 months	Mother with retinopathy	Retinopathy(OS), Iris cyst(OU)	None	Exon 4-10 deletion(maternal origin)		
All patients were confirmed by skin biopsy

*The boy’s saliva DNA showed a mosaicism consisting of the deletion and intact alleles, but his blood DNA did not. Relative quantification analysis of the real-time PCR data estimated the mosaicism ratio of the boy’s saliva as 45:55 (deletion:intact)

Fig 4. Genomic organization of NEMO vs. ΔNEMO and their recurrent deletion. a Tail-to-tail alignment of NEMO and ΔNEMO (a). In the NEMO gene, exons are shown as 1D, A–C, and 2–10; 1D and A–C indicate 4 alternative versions of exon 1: 1D (GenBank: NM_001377312.1), 1A (NM_001099856.6), 1B (NM_001321396.3), and 1C (NM_003639.4). Noncoding and coding exons are shown as white and black boxes, respectively. The longer black box of exons 4–10 also contains introns. On the ΔNEMO side, corresponding positions to each of the NEMO exons are shown except for the 4 alternative versions of exon 1, which are missing in ΔNEMO. The pentagons on the NEMO and ΔNEMO sides show the highly homologous duplicated sequences. The arrows with dotted lines indicate the lengths of the duplicated sequences and the distance between them. The identical MER67B repeats are shown as dotted triangular areas on both the NEMO and ΔNEMO sides. The PCR primers are shown by arrows with solid lines. The expected sizes of the PCR products are indicated by the solid lines with short bars at the ends. b The genomic structure of a NEMO allele generated by recurrent exon 4–10 deletion. An 11.7-kb sequence is lost due to the deletion. The PCR product size, specific to the recurrent exon 4–10 deletion, is indicated by an enclosing line (3032 and 1045 bp). c The genomic structure of a ΔNEMO allele generated at the position homologous to NEMO. d The sequence of the primers used to examine the genomic structure of the NEMO allele with the recurrent deletion. e The primer positions for the real-time PCR used to quantify the NEMO and ΔNEMO copy number. See reference [73] for the primer sequences

Rare genotypes and rare phenotype

(1) Isodisomy

Isodisomy is a rare genetic abnormality in which a chromosome from the father or mother is duplicated. Its cause is a biological reaction that prevents trisomy [74–76]. IRD due to isodisomy is rare; however, a few cases have been reported [77, 78]. Through a detailed review of genomic data, we identified two cases, a girl (Case 1) and a man (Case 2) [78].

Case 1 had nystagmus since birth and made a first visit to our hospital at 8 years of age. Fundus examination revealed narrowing of the retinal vessels and changes in the retinal pigment epithelium. Optical coherence tomography (OCT) showed severe thinning of the retina (Fig. 5). The visual field showed progressive afferent visual field constriction, and ERG had an obliterating pattern, leading to the diagnosis of early-onset retinal dystrophy. Genetic analysis suggested a maternal UPD on chromosome 4. With loss of heterozygosity, the patient showed a homozygous variant of the SRD5A3 gene. The variant was in the transmembrane domain and substituted a conserved amino acid among vertebrates. We examined glucosylation using serum transferrin at the Osaka Women’s and Children’s Hospital, diagnosing the first congenital dysglucosylation type 1q (OMIM 612379) in Japan.Fig 5. a Right fundus photography at 9 years of age (left) and an optical coherence tomography (OCT) image at 10 years of age (right). The fundus photography shows poor retinal color and narrowing of the retinal blood vessels. Although the OCT images are poor due to nystagmus, retinal thinning and the ellipsoid zone (EZ) line disappearance are observed. b The visual field is examined at 9 (left) and 14 years of age (right). The visual field is progressively constricted. c Right fundus photograph at 26 years of age (left) showing poor retinal color and narrowing of the retinal blood vessels and (right) an OCT image at 31 years of age showing the retina is highly thinning; the EZ line is not observable. d The visual field is examined at 26 years of age (left) and fundus autofluorescence (FAF) at 14 years of age (right). The visual field is severely constricted; the FAF shows low fluorescence, consistent with retinal degeneration [78]

A 31-year-old male patient presented with photophobia and night blindness at 7 years of age and was diagnosed with RP at 10 years of age. The visual field showed severe centripetal constriction; fundus examination revealed narrowing of retinal vessels, numerous pigment spots in the middle periphery, and degeneration of the macular area (Fig. 5c, d). ERG showed an obliterating pattern. OCT showed severe retinal thinning; fundus autofluorescence (FAF) showed hypofluorescence, leading to the diagnosis of RP with early macular involvement. Genetic analysis suggested a maternal UPD on chromosome 8. Loss of heterozygosity was observed in chromosome 8, including the RP1 gene; the Integrative Genomics Viewer showed a sharp decrease in sequencing depth in exon 4 of RP1, suggesting an Alu insertion. Based on these results, our diagnosis was RP1-related RP (OMIM 180100). This Alu insertion is a causative variant of the disease recently reported [50]. We consider it a major cause of RP1-related retinal dystrophy in Japan [49, 79]. A homozygous Alu insertion was confirmed in the patient by PCR; the mother was a carrier of the insertion. Most cases of IRD due to isodisomy occur in children. This finding should be considered during genetic counseling for IRD in children.

(2) Juvenile-onset retinal dystrophy caused by double mutations

Double mutations have been documented in diverse medical conditions. Some reports come from the ophthalmology field [80–82]. The proband was a patient with congenital stationary night blindness (CSNB) at the Jikei University School of Medicine in Tokyo (Patient II-2 in Fig. 6); two children (Patients III-1 and III-2) showed abnormal retinal dystrophies in both cones and rods [83]. Patient III-1 showed a grayish color change within the vascular arcade; Patient III-2 showed no abnormality. FAF showed a ring of hyperfluorescence. OCT showed thinning of the retina in the macular area with loss of the ellipsoid zone (EZ) line. The ERGs of Patients II-2 and II-3 with the International Society for Clinical Electrophysiology of Vision protocol were generally consistent with the ERG of Nougaret-type CSNB (OMIM# 610444) (Fig. 7), including obliterated rod responses, normal cone responses, and clear ON-OFF responses [84, 85]. Patients III-2 and III-1, who had juvenile-onset cone-rod dystrophy, showed reduced cone and 30-Hz flicker responses in addition to the loss of rod responses. Genetic testing of the family history revealed a heterozygous p.G38D missense variant of the GNAT1 gene, which may have caused the rod abnormality. Furthermore, we identified a compound heterozygous variant of spliced and nonsense mutations in the ABCA4 gene in Patients III-1 and III-2 in addition to the missense GNAT1 variant. We consider that Patients III-1 and III-2 have the phenotype of juvenile-onset cone-rod dystrophy overlapping with Nougaret-type CSNB.Fig 6. Pedigree of a Japanese family showing nucleotide sequences of exon 2 of the GNAT1 gene. Unaffected members are shown as unfilled circles (female) or squares (males); patients with congenital stationary night blindness (CSNB) or cone-rod dystrophy (CORD) are shown as gray or black symbols, respectively. The female proband (II-2) is indicated by an arrow; ‘‘wt’’ denotes the wild-type genotype. A heterozygous GNAT1 variant (p.G38D) is found in all examined patients with CSNB, including the proband. The patients with CORD (III-1) carry compound heterozygous ABCA4 variants (p.Q185X and c.1760+2>G) [83].

Fig 7. Full-field electroretinography (ERG) findings of a control participant, two patients (II-2 and II-3) with congenital stationary night blindness (CSNB), and two patients (III-1 and III-2) with cone-rod dystrophy (CORD). The ERG of patient II-2 (CSNB) shows a non-recordable rod response (dark-adapted 0.01 cd·s·m-2; DA 0.01) but at least 50% greater than normal a- and b-wave responses in DA 3.0, DA 10.0, and DA 200 ERG after 30 min of DA in the right eye and 24 h of DA in the left eye. The cone (light-adapted 3.0 cd·s·m-2; LA 3.0) and 30-Hz flicker (LA 3.0 flicker) responses are normal. Clear on and off responses are observed. The ERG findings of patient II-3 (CSNB) are comparable with those of patient II-2. In patients III-2 and III-1 (CORD), the DA ERG shows a non-recordable rod response (DA0.01) and severely decreased a- and b-wave responses to a strong flash (DA 3.0) but only about one-third of the normal response to a greater flash (DA 200). The LA 3.0 and LA 3.0 flicker responses are severely decreased in III-2, consistent with CORD features [83]

(3) LHON-like optic neuropathy in patients with RP due to COQ2 gene abnormality

A 27-year-old male patient was referred to us for genetic counseling for RP. Before visiting our hospital, the patient expressed concerns about vision difficulties in his left eye. A diagnosis of RP was made based on visual field and fundus findings. Redness was observed in the right optic nerve papilla, and fluorescence fundus angiography showed telangiectasia around the optic nerve papillary vessels in the right eye (Fig. 8). The correlation between treatment and visual function was similar to that reported in 1993 for LHON, in which visual acuity was restored [4]. A case of double mutation in the RP2 gene and the 11778 mutation of the mitochondrial gene had been reported [86]. We performed a genetic analysis of this case, suspecting it might be a similar abnormality. Although no variant was found in the mitochondrial gene, whole exome analysis revealed a known compound heterozygous missense mutation in the COQ2 gene. RP due to mutations in the COQ2 gene has been reported [87]. COQ2 is an enzyme essential for the biosynthesis of COQ10. We propose that the COQ2 mutations cause mitochondrial electron transfer system dysfunction, resulting in LHON-like optic neuropathy [88].Fig 8. a Fundus findings of a patient. Color fundus photography at the first visit shows diffused retinal degeneration, including bone–spicule pigmentation and narrowed retinal vessels. b Optic disc findings of the patient. The optic disc is hyperemic in the right eye and pale in the left eye at the first visit (left row). The optic discs are pale in both eyes at the last visit (right row). c OCT findings of the patient. OCT at the first visit reveals relatively preserved inner retinal layers. Thinning of the outer nuclear layer and disruption of the EZ line are seen from the parafoveal area to the surrounding area. d Fluorescein angiography at the first visit reveals peripapillary telangiectatic blood vessels in the early phase in the right eye (left row) and neither staining nor leakage around the optic disc in the late phase in both eyes (middle and right row). OD: oculus dexter; OS: oculus sinister [88].

An autosomal recessive form of LHON (LHONAR1, arLHON, MIM: #619382) has recently been reported. The autosomal recessive form of LHON is caused mainly by biallelic variants in the DNAJC30 gene (MIM: 618202) [89, 90]. Typical LHON phenotypes have also been reported to be caused by variants in other genes: NDUFS2, MCAT, and NDUFA12, detected only in a few families [90]. The prevalence of LHON caused by these gene variants in Japanese patients is unknown. Pathogenic variants of the DNAJC30 gene are reported to affect the mitochondrial complex I subunit and interact with mitochondrial adenosine triphosphate synthesis [89]. Mitochondrial electron transport chain dysfunction is significantly involved in LHON pathology.

COQ2 gene variants are known to cause multiple system atrophy [87]. This phenomenon is called an incidental finding/secondary finding (IF/SF) and is a major issue to be considered when expanding the scope of genetic testing. No systemic abnormalities have been observed in the patient in which this was identified except for a relatively low platelet count; however, the patient is being carefully monitored by a neurologist.

Most inherited eye diseases are caused by one variant in the cases of dominant inheritance or two variants in the cases of recessive inheritance. Although rare, complex genetic abnormalities also occur. Multiple variants can affect the disease phenotype, or one variant may be involved in several diseases; defining the effect of each variant is presently difficult.

Clinical application

(1) Genetic counseling for genetic diseases in Japan

At the beginning of the 20th century, consanguineous marriages in Japan were much more common than in other industrialized countries, but they have rapidly decreased [21, 91] (Fig. 9). Avoiding consanguineous marriages is crucial, as is continuing educational efforts on this subject as a proactive measure in managing hereditary eye diseases. We collaborated with the Department of Otorhinolaryngology, Hamamatsu University School of Medicine, and the Preeminent Medical Photonics Education & Research Center for genetic analysis of Usher Syndrome [92–95]. The USH2A gene is a representative causative gene of Usher syndrome. We have already described the USH2A gene analysis of RP without hearing loss before. The results of the USH2A gene analysis of the otorhinolaryngology cohort were all compound heterozygous variants [92]. Although preventing hereditary eye diseases caused by compound heterozygous variants is difficult, risk assessment by genetic testing of spouses and genetic counseling are promising countermeasures.Fig 9. Rate of consanguineous marriage in Japan. ●: Rate of consanguineous marriage (%). ○: Rate of cousin marriage (%). Among advanced countries, Japan had an exceptionally high number of incestuous marriages, but the number has decreased rapidly in recent years [21, 91]

(2) Predicting the prognosis of inherited eye diseases

Clarifying the causative variant facilitates predicting the prognosis. Taking IRD as an example, three types of genetic abnormalities occur: (1) those causing significant visual impairment from infancy, (2) those causing problems in childhood, and (3) those causing problems in adulthood. Further documentation of cases and the clinical identification of each variant will enable prognoses to be predicted more accurately.

Family tree analysis identified that XLRP is rare in Japan [96]. However, genetic diagnoses revealed that variants of the RPGR and RP2 genes were found in isolated cases; large-scale analyses revealed they are not rare [41–43]. We examined the clinical profile of patients from 12 families with causative RPGR (n=7) and RP2 (n=5) variants and female carriers [97]. Male patients had severe visual dysfunction, and the RP2 variant was slightly more severe (Fig. 10).Fig 10. Correlation between visual function and age among affected Japanese patients with X-linked RP. a The graphs show visual acuity values expressed in logMAR units, b refractive error, c visual field extent with the V-4e isopter, d and visual field extent with the I-4e isopter versus age. The data from the same participant are indicated by bars connecting the points [97]

Female carriers of XLRP vary from being asymptomatic to severely impaired. FAF shows patchy radial hyperfluorescence, which is more common in wide-angle imaging [98, 99]. Attempts have been made to grade carriers of XLRP according to fundus findings. Table 3 shows the visual function of XLRP carriers by grade of fundus finding. The visual function of carriers of XLRP with severe myopia is considered more severe in older patients. Some patients diagnosed with severe myopic chorioretinal atrophy may be carriers of XLRP. The reason why carriers of XLRP with high myopia are affected more severely is unknown.Table 3. Relation of fundus grade and visual function in female carriers of XLRP [97]

	Grade 0	Grade 1	Grade 2	Grade 3	J-T Test	
Age (years)	53	35.7	62.6	67.6	p = 0.001 **	
BCVA (logMAR unit)	− 0.015	− 0.079	0.2	0.47	p = 0.005 **	
Refractive error (diopters)	− 1.81	− 3.29	− 5.06	− 14.04	p = 0.001 **	
Visual field area (mm2)						
V-4e isopter	20619	22716	21540	12439	p = 0.046 *	
I-4e isopter	9343	11443	10312	6198	p = 0.062	
J-T Jonckheere–Terpstra; *: significant at p < 0.05, **: significant at p < 0.01

(3) Gene therapy

Since the 1980s, gene transfer methods have been studied for hereditary eye diseases [100–102]. Clinical trials underway for IRD in Europe and the USA use mainly adeno-associated virus (AAV) vectors [103, 104]. Clinical trials for LCA caused by RPE65 gene abnormalities have also started in Japan. Although developing a treatment effective for all types of IRD is desirable, most investigations are focused on treatment methods specific to the causative gene. AAV vectors are relatively safe because they exist as episomes and do not incorporate into the host’s DNA [105, 106]. However, in addition to long-term efficacy, developing drugs that are safe even when administered for a long period is desirable.

EYS gene abnormalities are among the most important causes of RP leading to blindness in Japan. The EYS gene-related patients can often adapt to society until 50 years of age. If the rate of progression can be halved, they may be able to adapt throughout their lives. The problem in developing a treatment for RP is that the EYS gene does not exist in most other mammals, making animal experiments difficult. In addition, the gene is so large that inserting it into a vector is difficult. We have observed and reported retinal dystrophies over a long period [107–109]. Understanding the natural course of the disease is imperative for accurately assessing the efficacy of treatment interventions.

Conclusion

Ocular genome research has progressed rapidly over the past 30 years. The knowledge of ocular genetics has become vast and continues to grow. Genetic counseling, prognosis prediction, and gene therapy have shown effectiveness in patient interventions. Although expectations are high, many issues need to be considered, including the social and familial stigma of a genetic diagnosis, IF/SF, long-term effects of gene therapy, and safety. By understanding patient diversity through genetic diagnoses and formulating parameters to assess responses to both the environment and drugs, the efficacy of treatments for hereditary eye diseases can be rapidly determined. This approach enables establishing evidence-based methods for addressing these conditions within a limited timeframe. Expectations for the future of precision medicine extend beyond the scope of genetic diagnoses. Above all, providing patients suffering from intractable diseases with hope and accurate information is crucial.

Acknowledgements

I would like to express my deep gratitude to Dr. Noriyuki Azuma, Prof. Miho Sato, Prof. Takaaki Hayashi, and Prof. Hirotomo Saitsu for their outstanding support. We would like to thank Dr. Miwa Komori for her cooperation. I would also like to thank the doctors and the participants for their cooperation in conducting the research.

Funding

This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C), grant number JP20K09825 to Y.H., 23K09041 to K.T.; a grant from the Initiative on Rare and Undiagnosed Diseases, number JP23ek0109549 from the Japan Agency for Medical Research and Development (AMED); the Health and Labour Sciences, Research Grant of Research on Intractable Diseases, number 23FC1055 to Y.H.

Declarations

Conflicts of interest

Y. Hotta, None; K. Torii, None; M. Takayama, None.

Organizer: Satoshi Kashii, MD.

Corresponding Author: Yoshihiro Hotta.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Wallace DC Singh G Lott MT Hodge JA Schurr TG Lezza AM Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy Science 1988 242 1427 1430 10.1126/science.3201231 3201231
Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science. 1988;242:1427–30.3201231
2. Yoneda M Tsuji S Yamauchi T Inuzuka T Miyatake T Horai S Mitochondrial DNA mutation in family with Leber’s hereditary optic neuropathy Lancet 1989 1 1076 1077 10.1016/S0140-6736(89)92470-7 2566021
Yoneda M, Tsuji S, Yamauchi T, Inuzuka T, Miyatake T, Horai S, et al. Mitochondrial DNA mutation in family with Leber’s hereditary optic neuropathy. Lancet. 1989;1:1076–7.2566021
3. Hotta Y Hayakawa M Saito K Kanai A Nakajima A Fujiki K Diagnosis of Leber’s optic neuropathy by means of polymerase chain reaction amplification Am J Ophthalmol 1989 108 601 602 10.1016/0002-9394(89)90444-3 2817063
Hotta Y, Hayakawa M, Saito K, Kanai A, Nakajima A, Fujiki K. Diagnosis of Leber’s optic neuropathy by means of polymerase chain reaction amplification. Am J Ophthalmol. 1989;108:601–2.2817063
4. Hotta Y Hayakawa M Fujiki K Shinohara K Sado K Kanai A Yanashima K An atypical Leber’s hereditary optic neuropathy with the 11778 mutation Br J Ophthalmol 1993 77 11 748 10.1136/bjo.77.11.748 8280696
Hotta Y, Hayakawa M, Fujiki K, Shinohara K, Sado K, Kanai A, Yanashima K. An atypical Leber’s hereditary optic neuropathy with the 11778 mutation. Br J Ophthalmol. 1993;77(11):748.8280696
5. Nakamura M Ara F Yamada M Hotta Y Hayakawa M Fujiki K High frequency of mitochondrial ND4 gene mutation in Japanese pedigrees with Leber hereditary optic neuropathy Jpn J Ophthalmol 1992 36 56 61 1635296
Nakamura M, Ara F, Yamada M, Hotta Y, Hayakawa M, Fujiki K, et al. High frequency of mitochondrial ND4 gene mutation in Japanese pedigrees with Leber hereditary optic neuropathy. Jpn J Ophthalmol. 1992;36:56–61.1635296
6. Newman NJ Lott MT Wallace DC The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation Am J Ophthalmol 1991 111 750 762 10.1016/S0002-9394(14)76784-4 2039048
Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber’s hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol. 1991;111:750–62.2039048
7. Hotta Y Fujiki K Hayakawa M Nakajima A Kanai A Mashima Y Clinical features of Japanese Leber’s hereditary optic neuropathy with 11778 mutation of mitochondrial DNA Jpn J Ophthalmol 1995 39 96 108 7643491
Hotta Y, Fujiki K, Hayakawa M, Nakajima A, Kanai A, Mashima Y, et al. Clinical features of Japanese Leber’s hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol. 1995;39:96–108.7643491
8. Munier FL Korvatska E Djemaï A Le Paslier D Zografos L Pescia G Kerato-epithelin mutations in four 5q31-linked corneal dystrophies Nat Genet 1997 15 247 251 10.1038/ng0397-247 9054935
Munier FL, Korvatska E, Djemaï A, Le Paslier D, Zografos L, Pescia G, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet. 1997;15:247–51.9054935
9. Hotta Y Inherited ocular diseases Nippon Ganka Gakkai Zasshi 2006 110 545 559
Hotta Y. Inherited ocular diseases. Nippon Ganka Gakkai Zasshi. 2006;110:545–59.
10. Fujiki K Hotta Y Nakayasu K Kanai A Homozygotic patient with betaig-h3 gene mutation in granular dystrophy Cornea 1998 17 288 292 10.1097/00003226-199805000-00009 9603385
Fujiki K, Hotta Y, Nakayasu K, Kanai A. Homozygotic patient with betaig-h3 gene mutation in granular dystrophy. Cornea. 1998;17:288–92.9603385
11. Fujiki K Hotta Y Nakayasu K Yokoyama T Takano T Yamaguchi T A new L527R mutation of the βIGH3 gene in patients with lattice corneal dystrophy with deep stromal opacities Hum Genet 1998 103 286 289 10.1007/s004390050818 9799082
Fujiki K, Hotta Y, Nakayasu K, Yokoyama T, Takano T, Yamaguchi T, et al. A new L527R mutation of the βIGH3 gene in patients with lattice corneal dystrophy with deep stromal opacities. Hum Genet. 1998;103:286–9.9799082
12. Hotta Y Fujiki K Ono K Fujimaki T Nakayasu K Yamaguchi T Arg124Cys mutation of the βig-h3 gene in a Japanese family with lattice corneal dystrophy type I Jpn J Ophthalmol 1998 42 450 455 10.1016/S0021-5155(98)00050-1 9886734
Hotta Y, Fujiki K, Ono K, Fujimaki T, Nakayasu K, Yamaguchi T, et al. Arg124Cys mutation of the βig-h3 gene in a Japanese family with lattice corneal dystrophy type I. Jpn J Ophthalmol. 1998;42:450–5.9886734
13. Endo S Nguyen TH Fujiki K Hotta Y Nakayasu K Yamaguchi T A. Leu518Pro mutation of the βig-h3 gene causes lattice corneal dystrophy type I Am J Ophthalmol 1999 128 104 106 10.1016/S0002-9394(99)00053-7 10482106
Endo S, Nguyen TH, Fujiki K, Hotta Y, Nakayasu K, Yamaguchi T, et al. A. Leu518Pro mutation of the βig-h3 gene causes lattice corneal dystrophy type I. Am J Ophthalmol. 1999;128:104–6.10482106
14. Hirano K Hotta Y Fujiki K Kanai A Corneal amyloidosis caused by Leu518Pro mutation of βig-h3 gene Br J Ophthalmol 2000 84 583 585 10.1136/bjo.84.6.583 10837380
Hirano K, Hotta Y, Fujiki K, Kanai A. Corneal amyloidosis caused by Leu518Pro mutation of βig-h3 gene. Br J Ophthalmol. 2000;84:583–5.10837380
15. Ha NT Fujiki K Hotta Y Nakayasu K Kanai A Q118X mutation of M1S1 gene caused gelatinous drop-like corneal dystrophy: the P501T of BIGH3 gene found in a family with gelatinous drop-like corneal dystrophy Am J Ophthalmol 2000 130 119 120 10.1016/S0002-9394(00)00596-1 11004271
Ha NT, Fujiki K, Hotta Y, Nakayasu K, Kanai A. Q118X mutation of M1S1 gene caused gelatinous drop-like corneal dystrophy: the P501T of BIGH3 gene found in a family with gelatinous drop-like corneal dystrophy. Am J Ophthalmol. 2000;130:119–20.11004271
16. Fujiki K Hotta Y Nakayasu K Yamaguchi T Kato T Uesugi Y Six different mutations of TGFBI (betaig-h3, keratoepithelin) gene found in Japanese corneal dystrophies Cornea 2000 19 842 845 10.1097/00003226-200011000-00015 11095060
Fujiki K, Hotta Y, Nakayasu K, Yamaguchi T, Kato T, Uesugi Y, et al. Six different mutations of TGFBI (betaig-h3, keratoepithelin) gene found in Japanese corneal dystrophies. Cornea. 2000;19:842–5.11095060
17. Hirano K Hotta Y Nakamura M Fujiki K Kanai A Yamamoto N Late-onset form of lattice corneal dystrophy caused by leu527Arg mutation of the TGFBI gene Cornea 2001 20 525 529 10.1097/00003226-200107000-00017 11413411
Hirano K, Hotta Y, Nakamura M, Fujiki K, Kanai A, Yamamoto N. Late-onset form of lattice corneal dystrophy caused by leu527Arg mutation of the TGFBI gene. Cornea. 2001;20:525–9.11413411
18. Hirano K Kojima T Nakamura M Hotta Y Triple anterior chamber after full-thickness lamellar keratoplasty for lattice corneal dystrophy Cornea 2001 20 530 533 10.1097/00003226-200107000-00018 11413412
Hirano K, Kojima T, Nakamura M, Hotta Y. Triple anterior chamber after full-thickness lamellar keratoplasty for lattice corneal dystrophy. Cornea. 2001;20:530–3.11413412
19. Yasumi K Nojima K Hosono K Hotta Y A case of lattice corneal dystrophy with p. (L527R) mutation in the TGFBI gene Rinsho Ganka 2020 74 1120 1125
Yasumi K, Nojima K, Hosono K, Hotta Y. A case of lattice corneal dystrophy with p. (L527R) mutation in the TGFBI gene. Rinsho Ganka. 2020;74:1120–5.
20. Yamada N The genetic diagnosis of the corneal dystrophies Rinsho Ganka 2017 71 164 174
Yamada N. The genetic diagnosis of the corneal dystrophies. Rinsho Ganka. 2017;71:164–74.
21. Hotta Y Toward genomic medicine: research and clinical application in ocular genetics Nippon Ganka Gakkai Zasshi 2021 127 297 328
Hotta Y. Toward genomic medicine: research and clinical application in ocular genetics. Nippon Ganka Gakkai Zasshi. 2021;127:297–328.
22. Yamamoto H Simon A Eriksson U Harris E Berson EL Dryja TP Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus Nat Genet 1999 22 188 191 10.1038/9707 10369264
Yamamoto H, Simon A, Eriksson U, Harris E, Berson EL, Dryja TP. Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus. Nat Genet. 1999;22:188–91.10369264
23. Nakamura M Hotta Y Tanikawa A Terasaki H Miyake Y A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene Invest Ophthalmol Vis Sci 2000 41 3925 3932 11053295
Nakamura M, Hotta Y, Tanikawa A, Terasaki H, Miyake Y. A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene. Invest Ophthalmol Vis Sci. 2000;41:3925–32.11053295
24. Hotta Y Nakamura M Okamoto Y Nomura R Terasaki H Miyake Y Different mutation of the XLRS1 gene causes juvenile retinoschisis with retinal white flecks Br J Ophthalmol 2001 85 238 239 10.1136/bjo.85.2.238 11225572
Hotta Y, Nakamura M, Okamoto Y, Nomura R, Terasaki H, Miyake Y. Different mutation of the XLRS1 gene causes juvenile retinoschisis with retinal white flecks. Br J Ophthalmol. 2001;85:238–9.11225572
25. Schatz P Preising M Lorenz B Sander B Larsen M Rosenberg T Fundus albipunctatus associated with compound heterozygous mutations in RPE65 Ophthalmology 2011 118 888 894 10.1016/j.ophtha.2010.09.005 21211845
Schatz P, Preising M, Lorenz B, Sander B, Larsen M, Rosenberg T. Fundus albipunctatus associated with compound heterozygous mutations in RPE65. Ophthalmology. 2011;118:888–94.21211845
26. Yang G Liu Z Xie S Li C Lv L Zhang M Zhao J Genetic and phenotypic characteristics of four Chinese families with fundus albipunctatus Sci Rep 2017 7 46285 10.1038/srep46285 28393863
Yang G, Liu Z, Xie S, Li C, Lv L, Zhang M, Zhao J. Genetic and phenotypic characteristics of four Chinese families with fundus albipunctatus. Sci Rep. 2017;7:46285.28393863
27. Katagiri S Hosono K Hayashi T Kurata K Mizobuchi K Matsuura T Early onset flecked retinal dystrophy associated with new compound heterozygous RPE65 variants Mol Vis 2018 24 286 296 29681726
Katagiri S, Hosono K, Hayashi T, Kurata K, Mizobuchi K, Matsuura T, et al. Early onset flecked retinal dystrophy associated with new compound heterozygous RPE65 variants. Mol Vis. 2018;24:286–96.29681726
28. Nojima K Hosono K Zhao Y Toshiba T Hikoya A Asai T Clinical features of a Japanese case with Bothnia dystrophy Ophthalmic Genet 2012 33 83 88 10.3109/13816810.2011.634877 22171637
Nojima K, Hosono K, Zhao Y, Toshiba T, Hikoya A, Asai T, et al. Clinical features of a Japanese case with Bothnia dystrophy. Ophthalmic Genet. 2012;33:83–8.22171637
29. Katsanis N Shroyer NF Lewis RA Cavender JC Al-Rajhi AA Jabak M Fundus albipunctatus and retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1 Clin Genet 2001 59 424 429 10.1034/j.1399-0004.2001.590607.x 11453974
Katsanis N, Shroyer NF, Lewis RA, Cavender JC, Al-Rajhi AA, Jabak M, et al. Fundus albipunctatus and retinitis punctata albescens in a pedigree with an R150Q mutation in RLBP1. Clin Genet. 2001;59:424–9.11453974
30. Chizzolini M Galan A Milan E Sebastiani A Costagliola C Parmeggiani F Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking Curr Genom 2011 12 260 266 10.2174/138920211795860071
Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genom. 2011;12:260–6.
31. Dryja TP McGee TL Hahn LB Cowley GS Olsson JE Reichel E Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa N Engl J Med 1990 323 1302 1307 10.1056/NEJM199011083231903 2215617
Dryja TP, McGee TL, Hahn LB, Cowley GS, Olsson JE, Reichel E, et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 1990;323:1302–7.2215617
32. Hotta Y Shiono T Hayakawa M Hashimoto T Kanai A Nakajima A Molecular biological study of the rhodopsin gene in Japanese patients with autosomal dominant retinitis pigmentosa Nippon Ganka Gakkai Zasshi 1992 96 237 242 1558021
Hotta Y, Shiono T, Hayakawa M, Hashimoto T, Kanai A, Nakajima A, et al. Molecular biological study of the rhodopsin gene in Japanese patients with autosomal dominant retinitis pigmentosa. Nippon Ganka Gakkai Zasshi. 1992;96:237–42.1558021
33. Hayakawa M Hotta Y Imai Y Fujiki K Nakamura A Yanashima K Clinical features of autosomal dominant retinitis pigmentosa with rhodopsin gene codon 17 mutation and retinal neovascularization in a Japanese patient Am J Ophthalmol 1993 115 168 173 10.1016/S0002-9394(14)73920-0 7679248
Hayakawa M, Hotta Y, Imai Y, Fujiki K, Nakamura A, Yanashima K, et al. Clinical features of autosomal dominant retinitis pigmentosa with rhodopsin gene codon 17 mutation and retinal neovascularization in a Japanese patient. Am J Ophthalmol. 1993;115:168–73.7679248
34. Fujiki K Hotta Y Murakami A Yoshii M Hayakawa M Ichikawa T Missense mutation of rhodopsin gene codon 15 found in Japanese autosomal dominant retinitis pigmentosa Jpn J Hum Genet 1995 40 271 277 10.1007/BF01876186 8527802
Fujiki K, Hotta Y, Murakami A, Yoshii M, Hayakawa M, Ichikawa T, et al. Missense mutation of rhodopsin gene codon 15 found in Japanese autosomal dominant retinitis pigmentosa. Jpn J Hum Genet. 1995;40:271–7.8527802
35. Sakai D Hiraoka M Matsuzaki M Yokota S Hirami Y Onishi A Genotype and phenotype characteristics of RHO-associated retinitis pigmentosa in the Japanese population Jpn J Ophthalmol 2023 67 138 148 10.1007/s10384-023-00975-y 36648560
Sakai D, Hiraoka M, Matsuzaki M, Yokota S, Hirami Y, Onishi A, et al. Genotype and phenotype characteristics of RHO-associated retinitis pigmentosa in the Japanese population. Jpn J Ophthalmol. 2023;67:138–48.36648560
36. Abd El-Aziz MM Barragan I O’Driscoll CA Goodstadt L Prigmore E Borrego S EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa Nat Genet 2008 40 1285 1287 10.1038/ng.241 18836446
Abd El-Aziz MM, Barragan I, O’Driscoll CA, Goodstadt L, Prigmore E, Borrego S, et al. EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa. Nat Genet. 2008;40:1285–7.18836446
37. Collin RW Littink KW Klevering BJ van den Born LI Koenekoop RK Zonneveld MN Identification of a 2 Mb human ortholog of Drosophila eyes shut/spacemaker that is mutated in patients with retinitis pigmentosa Am J Hum Genet 2008 83 594 603 10.1016/j.ajhg.2008.10.014 18976725
Collin RW, Littink KW, Klevering BJ, van den Born LI, Koenekoop RK, Zonneveld MN, et al. Identification of a 2 Mb human ortholog of Drosophila eyes shut/spacemaker that is mutated in patients with retinitis pigmentosa. Am J Hum Genet. 2008;83:594–603.18976725
38. Audo I Sahel JA Mohand-Saïd S Lancelot ME Antonio A Moskova-Doumanova V EYS is a major gene for rod-cone dystrophies in France Hum Mutat 2010 31 E1406 E1435 10.1002/humu.21249 20333770
Audo I, Sahel JA, Mohand-Saïd S, Lancelot ME, Antonio A, Moskova-Doumanova V, et al. EYS is a major gene for rod-cone dystrophies in France. Hum Mutat. 2010;31:E1406–35.20333770
39. Hosono K Ishigami C Takahashi M Park DH Hirami Y Nakanishi H Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population PLoS ONE 2012 7 e31036 10.1371/journal.pone.0031036 22363543
Hosono K, Ishigami C, Takahashi M, Park DH, Hirami Y, Nakanishi H, et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS ONE. 2012;7:e31036.22363543
40. Iwanami M Oshikawa M Nishida T Nakadomari S Kato S High prevalence of mutations in the EYS gene in Japanese patients with autosomal recessive retinitis pigmentosa Invest Ophthalmol Vis Sci 2012 53 1033 1040 10.1167/iovs.11-9048 22302105
Iwanami M, Oshikawa M, Nishida T, Nakadomari S, Kato S. High prevalence of mutations in the EYS gene in Japanese patients with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2012;53:1033–40.22302105
41. Oishi M Oishi A Gotoh N Ogino K Higasa K Iida K Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing Invest Ophthalmol Vis Sci 2014 55 7369 7375 10.1167/iovs.14-15458 25324289
Oishi M, Oishi A, Gotoh N, Ogino K, Higasa K, Iida K, et al. Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci. 2014;55:7369–75.25324289
42. Koyanagi Y Akiyama M Nishiguchi KM Momozawa Y Kamatani Y Takata S Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients J Med Genet 2019 56 662 670 10.1136/jmedgenet-2018-105691 31213501
Koyanagi Y, Akiyama M, Nishiguchi KM, Momozawa Y, Kamatani Y, Takata S, et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet. 2019;56:662–70.31213501
43. Suga A Yoshitake K Minematsu N Tsunoda K Fujinami K Miyake Y Genetic characterization of 1210 Japanese pedigrees with inherited retinal diseases by whole-exome sequencing Hum Mutat 2022 43 2251 2264 10.1002/humu.24492 36284460
Suga A, Yoshitake K, Minematsu N, Tsunoda K, Fujinami K, Miyake Y, et al. Genetic characterization of 1210 Japanese pedigrees with inherited retinal diseases by whole-exome sequencing. Hum Mutat. 2022;43:2251–64.36284460
44. Lee BJH Tham Y-C Tan T-E Bylstra Y Lim WK Jain K Characterizing the genotypic spectrum of retinitis pigmentosa in East Asian populations: a systematic review Ophthalmic Genet 2023 44 109 118 10.1080/13816810.2023.2182329 36856324
Lee BJH, Tham Y-C, Tan T-E, Bylstra Y, Lim WK, Jain K, et al. Characterizing the genotypic spectrum of retinitis pigmentosa in East Asian populations: a systematic review. Ophthalmic Genet. 2023;44:109–18.36856324
45. Iwanami M Oishi A Ogino K Seko Y Nishida-Shimizu T Yoshimura N Five major sequence variants and copy number variants in the EYS gene account for one-third of Japanese patients with autosomal recessive and simplex retinitis pigmentosa Mol Vis 2019 25 766 779 31814702
Iwanami M, Oishi A, Ogino K, Seko Y, Nishida-Shimizu T, Yoshimura N, et al. Five major sequence variants and copy number variants in the EYS gene account for one-third of Japanese patients with autosomal recessive and simplex retinitis pigmentosa. Mol Vis. 2019;25:766–79.31814702
46. Yang L Fujinami K Ueno S Kuniyoshi K Hayashi T Kondo M Genetic spectrum of EYS-associated retinal disease in a large Japanese cohort: Identification of disease-associated variants with relatively high allele frequency Sci Rep 2020 10 5497 10.1038/s41598-020-62119-3 32218477
Yang L, Fujinami K, Ueno S, Kuniyoshi K, Hayashi T, Kondo M, et al. Genetic spectrum of EYS-associated retinal disease in a large Japanese cohort: Identification of disease-associated variants with relatively high allele frequency. Sci Rep. 2020;10:5497.32218477
47. Tsunoda K Investigations of gene pathogenicity and establishment of a patient data bank for the hereditary chorioretinal dystrophy Nippon Ganka Gakkai Zasshi 2020 124 247 284
Tsunoda K. Investigations of gene pathogenicity and establishment of a patient data bank for the hereditary chorioretinal dystrophy. Nippon Ganka Gakkai Zasshi. 2020;124:247–84.
48. Murakami A Ophthalmologic genetics -molecular genetics and developments in therapeutic strategies for intractable eye diseases- Nippon Ganka Gakkai Zasshi 2021 125 210 228
Murakami A. Ophthalmologic genetics -molecular genetics and developments in therapeutic strategies for intractable eye diseases-. Nippon Ganka Gakkai Zasshi. 2021;125:210–28.
49. Nishiguchi KM Miya F Mori Y Fujita K Akiyama M Kamatani T A hypomorphic variant in EYS detected by genome-wide association study contributes toward retinitis pigmentosa Commun Biol. 2021 4 140 10.1038/s42003-021-01662-9 33514863
Nishiguchi KM, Miya F, Mori Y, Fujita K, Akiyama M, Kamatani T, et al. A hypomorphic variant in EYS detected by genome-wide association study contributes toward retinitis pigmentosa. Commun Biol. 2021;4:140.33514863
50. Nikopoulos K Cisarova K Quinodoz M Koskiniemi-Kuendig H Miyake N Farinelli P A frequent variant in the Japanese population determines quasi-Mendelian inheritance of rare retinal ciliopathy Nat Commun 2019 10 2884 10.1038/s41467-019-10746-4 31253780
Nikopoulos K, Cisarova K, Quinodoz M, Koskiniemi-Kuendig H, Miyake N, Farinelli P, et al. A frequent variant in the Japanese population determines quasi-Mendelian inheritance of rare retinal ciliopathy. Nat Commun. 2019;10:2884.31253780
51. Sano Y Koyanagi Y Wong JH Murakami Y Fujiwara K Endo M Likely pathogenic structural variants in genetically unsolved patients with retinitis pigmentosa revealed by long-read sequencing J Med Genet 2022 59 1133 1138 10.1136/jmedgenet-2022-108428 35710107
Sano Y, Koyanagi Y, Wong JH, Murakami Y, Fujiwara K, Endo M, et al. Likely pathogenic structural variants in genetically unsolved patients with retinitis pigmentosa revealed by long-read sequencing. J Med Genet. 2022;59:1133–8.35710107
52. Seyedahmadi BJ Rivolta C Keene JA Berson EL Dryja TP Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa Exp Eye Res 2004 79 167 173 10.1016/j.exer.2004.03.005 15325563
Seyedahmadi BJ, Rivolta C, Keene JA, Berson EL, Dryja TP. Comprehensive screening of the USH2A gene in Usher syndrome type II and non-syndromic recessive retinitis pigmentosa. Exp Eye Res. 2004;79:167–73.15325563
53. McGee TL Seyedahmadi BJ Sweeney MO Dryja TP Berson EL Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa J Med Genet 2010 47 499 506 10.1136/jmg.2009.075143 20507924
McGee TL, Seyedahmadi BJ, Sweeney MO, Dryja TP, Berson EL. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. J Med Genet. 2010;47:499–506.20507924
54. Zhao Y Hosono K Suto K Ishigami C Arai Y Hikoya A The first USH2A mutation analysis of Japanese autosomal recessive retinitis pigmentosa patients: a totally different mutation profile with the lack of frequent mutations found in Caucasian patients J Hum Genet 2014 59 521 528 10.1038/jhg.2014.65 25078356
Zhao Y, Hosono K, Suto K, Ishigami C, Arai Y, Hikoya A, et al. The first USH2A mutation analysis of Japanese autosomal recessive retinitis pigmentosa patients: a totally different mutation profile with the lack of frequent mutations found in Caucasian patients. J Hum Genet. 2014;59:521–8.25078356
55. Nagase Y Kurata K Hosono K Suto K Hikoya A Nakanishi H Visual outcomes in Japanese patients with retinitis pigmentosa and Usher syndrome caused by USH2A mutations Semin Ophthalmol 2018 33 560 565 10.1080/08820538.2017.1340487 28678594
Nagase Y, Kurata K, Hosono K, Suto K, Hikoya A, Nakanishi H, et al. Visual outcomes in Japanese patients with retinitis pigmentosa and Usher syndrome caused by USH2A mutations. Semin Ophthalmol. 2018;33:560–5.28678594
56. Hosono K Nishina S Yokoi T Katagiri S Saitsu H Kurata K Molecular diagnosis of 34 Japanese families with Leber congenital amaurosis using targeted next generation sequencing Sci Rep 2018 8 8279 10.1038/s41598-018-26524-z 29844330
Hosono K, Nishina S, Yokoi T, Katagiri S, Saitsu H, Kurata K, et al. Molecular diagnosis of 34 Japanese families with Leber congenital amaurosis using targeted next generation sequencing. Sci Rep. 2018;8:8279.29844330
57. Miyamichi D Nishina S Hosono K Yokoi T Kurata K Sato M Retinal structure in Leber’s congenital amaurosis caused by RPGRIP1 mutations Hum Genome Var 2019 6 32 10.1038/s41439-019-0064-8 31666973
Miyamichi D, Nishina S, Hosono K, Yokoi T, Kurata K, Sato M, et al. Retinal structure in Leber’s congenital amaurosis caused by RPGRIP1 mutations. Hum Genome Var. 2019;6:32.31666973
58. Hosono K Harada Y Kurata K Hikoya A Sato M Minoshima S Novel GUCY2D gene mutations in Japanese male twins with Leber congenital amaurosis J Ophthalmol 2015 2015 693468 10.1155/2015/693468 26097748
Hosono K, Harada Y, Kurata K, Hikoya A, Sato M, Minoshima S, et al. Novel GUCY2D gene mutations in Japanese male twins with Leber congenital amaurosis. J Ophthalmol. 2015;2015:693468.26097748
59. Torii K Nishina S Morikawa H Mizobuchi K Takayama M Tachibana N The structural abnormalities are deeply Involved in the cause of RPGRIP1-related retinal dystrophy in Japanese patients Int J Mol Sci 2023 24 13678 10.3390/ijms241813678 37761981
Torii K, Nishina S, Morikawa H, Mizobuchi K, Takayama M, Tachibana N, et al. The structural abnormalities are deeply Involved in the cause of RPGRIP1-related retinal dystrophy in Japanese patients. Int J Mol Sci. 2023;24:13678.37761981
60. Suzuki T Fujimaki T Yanagawa A Arai E Fujiki K Wada Y A novel exon 17 deletion mutation of RPGRIP1 gene in two siblings with Leber congenital amaurosis Jpn J Ophthalmol 2014 58 528 535 10.1007/s10384-014-0339-z 25096270
Suzuki T, Fujimaki T, Yanagawa A, Arai E, Fujiki K, Wada Y, et al. A novel exon 17 deletion mutation of RPGRIP1 gene in two siblings with Leber congenital amaurosis. Jpn J Ophthalmol. 2014;58:528–35.25096270
61. Pontikos N Arno G Jurkute N Schiff E Ba-Abbad R Malka S Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom Ophthalmology 2020 127 1384 1394 10.1016/j.ophtha.2020.04.008 32423767
Pontikos N, Arno G, Jurkute N, Schiff E, Ba-Abbad R, Malka S, et al. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom. Ophthalmology. 2020;127:1384–94.32423767
62. Terasaki H Miyake Y Association of acquired color vision defects in blue cone monochromatism Jpn J Ophthalmol 1995 39 55 59 7643484
Terasaki H, Miyake Y. Association of acquired color vision defects in blue cone monochromatism. Jpn J Ophthalmol. 1995;39:55–9.7643484
63. Wang C Hosono K Kachi S Suto K Nakamura M Terasaki H Novel OPN1LW/OPN1MW deletion mutations in 2 Japanese families with blue cone monochromacy Hum Genome Var. 2016 3 16011 10.1038/hgv.2016.11 27274860
Wang C, Hosono K, Kachi S, Suto K, Nakamura M, Terasaki H, et al. Novel OPN1LW/OPN1MW deletion mutations in 2 Japanese families with blue cone monochromacy. Hum Genome Var. 2016;3:16011.27274860
64. Nathans J Davenport CM Maumenee IH Lewis RA Hejtmancik JF Litt M Molecular genetics of human blue cone monochromacy Science 1989 245 831 838 10.1126/science.2788922 2788922
Nathans J, Davenport CM, Maumenee IH, Lewis RA, Hejtmancik JF, Litt M, et al. Molecular genetics of human blue cone monochromacy. Science. 1989;245:831–8.2788922
65. Nathans J Maumenee IH Zrenner E Sadowski B Sharpe LT Lewis RA Genetic heterogeneity among blue-cone monochromats Am J Hum Genet 1993 53 987 1000 8213841
Nathans J, Maumenee IH, Zrenner E, Sadowski B, Sharpe LT, Lewis RA, et al. Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet. 1993;53:987–1000.8213841
66. Buena-Atienza E Rüther K Baumann B Bergholz R Birch D De Baere E De novo intrachromosomal gene conversion from OPN1MW to OPN1LW in the male germline results in Blue Cone Monochromacy Sci Rep 2016 6 28253 10.1038/srep28253 27339364
Buena-Atienza E, Rüther K, Baumann B, Bergholz R, Birch D, De Baere E, et al. De novo intrachromosomal gene conversion from OPN1MW to OPN1LW in the male germline results in Blue Cone Monochromacy. Sci Rep. 2016;6:28253.27339364
67. Katagiri S Iwasa M Hayashi T Hosono K Yamashita T Kuniyoshi K Genotype determination of the OPN1LW/OPN1MW genes: novel disease-causing mechanisms in Japanese patients with blue cone monochromacy Sci Rep 2018 8 11507 10.1038/s41598-018-29891-9 30065301
Katagiri S, Iwasa M, Hayashi T, Hosono K, Yamashita T, Kuniyoshi K, et al. Genotype determination of the OPN1LW/OPN1MW genes: novel disease-causing mechanisms in Japanese patients with blue cone monochromacy. Sci Rep. 2018;8:11507.30065301
68. Wissinger B Baumann B Buena-Atienza E Ravesh Z Cideciyan AV Stingl K The landscape of submicroscopic structural variants at the OPN1LW/OPN1MW gene cluster on Xq28 underlying blue cone monochromacy Proc Natl Acad Sci USA 2022 119 e2115538119 10.1073/pnas.2115538119 35759666
Wissinger B, Baumann B, Buena-Atienza E, Ravesh Z, Cideciyan AV, Stingl K, et al. The landscape of submicroscopic structural variants at the OPN1LW/OPN1MW gene cluster on Xq28 underlying blue cone monochromacy. Proc Natl Acad Sci USA. 2022;119:e2115538119.35759666
69. Haseoka T Inagaki R Kurata K Arai S Takagi Y Suzuki H Usefulness of handheld electroretinogram system for diagnosing blue-cone monochromatism in children Jpn J Ophthalmol 2021 65 23 29 10.1007/s10384-020-00782-9 33135089
Haseoka T, Inagaki R, Kurata K, Arai S, Takagi Y, Suzuki H, et al. Usefulness of handheld electroretinogram system for diagnosing blue-cone monochromatism in children. Jpn J Ophthalmol. 2021;65:23–9.33135089
70. Scheuerle AE, Ursini MV. Incontinentia Pigmenti. In: Adam MP, Feldman J, Mirzaa GM, et al., eds.　GeneReviews at GeneTests: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle, 1997-2015. Available at http://www.genetests.org. Accessed february 1, 2017.
71. Aradhya S Woffendin H Jakins T Bardaro T Esposito T Smahi A A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations Hum Mol Genet 2001 10 2171 2179 10.1093/hmg/10.19.2171 11590134
Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A, et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001;10:2171–9.11590134
72. Hull S Arno G Thomson P Mutch S Webster AR Rai H Somatic mosaicism of a novel IKBKG mutation in a male patient with incontinentia pigmenti Am J Med Genet A 2015 167 1601 1604 10.1002/ajmg.a.37004 25944529
Hull S, Arno G, Thomson P, Mutch S, Webster AR, Rai H, et al. Somatic mosaicism of a novel IKBKG mutation in a male patient with incontinentia pigmenti. Am J Med Genet A. 2015;167:1601–4.25944529
73. Haque MN Ohtsubo M Nishina S Nakao S Yoshida K Hosono K Analysis of IKBKG/NEMO gene in five Japanese cases of incontinentia pigmenti with retinopathy: fine genomic assay of a rare male case with mosaicism J Hum Genet 2021 66 205 214 10.1038/s10038-020-00836-3 32908217
Haque MN, Ohtsubo M, Nishina S, Nakao S, Yoshida K, Hosono K, et al. Analysis of IKBKG/NEMO gene in five Japanese cases of incontinentia pigmenti with retinopathy: fine genomic assay of a rare male case with mosaicism. J Hum Genet. 2021;66:205–14.32908217
74. Engel E A new genetic concept: uniparental disomy and its potential effect, isodisomy Am J Med Genet 1980 6 137 143 10.1002/ajmg.1320060207 7192492
Engel E. A new genetic concept: uniparental disomy and its potential effect, isodisomy. Am J Med Genet. 1980;6:137–43.7192492
75. Spence JE Perciaccante RG Greig GM Willard HF Ledbetter DH Hejtmancik JF Uniparental disomy as a mechanism for human genetic disease Am J Hum Genet 1988 42 217 226 2893543
Spence JE, Perciaccante RG, Greig GM, Willard HF, Ledbetter DH, Hejtmancik JF, et al. Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet. 1988;42:217–26.2893543
76. Engel E A fascination with chromosome rescue in uniparental disomy: Mendelian recessive outlaws and imprinting copyrights infringements Eur J Hum Genet 2006 14 1158 1169 10.1038/sj.ejhg.5201619 16724013
Engel E. A fascination with chromosome rescue in uniparental disomy: Mendelian recessive outlaws and imprinting copyrights infringements. Eur J Hum Genet. 2006;14:1158–69.16724013
77. Thompson DA McHenry CL Li Y Richards JE Othman MI Schwinger E Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively Am J Hum Genet 2002 70 224 229 10.1086/338455 11727200
Thompson DA, McHenry CL, Li Y, Richards JE, Othman MI, Schwinger E, et al. Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively. Am J Hum Genet. 2002;70:224–9.11727200
78. Tachibana N Hosono K Nomura S Arai S Torii K Kurata K Maternal uniparental isodisomy of chromosome 4 and 8 in patients with retinal dystrophy: SRD5A3-congenital disorders of glycosylation and RP1-related retinitis pigmentosa Genes (Basel). 2022 13 359 10.3390/genes13020359 35205402
Tachibana N, Hosono K, Nomura S, Arai S, Torii K, Kurata K, et al. Maternal uniparental isodisomy of chromosome 4 and 8 in patients with retinal dystrophy: SRD5A3-congenital disorders of glycosylation and RP1-related retinitis pigmentosa. Genes (Basel). 2022;13:359.35205402
79. Mizobuchi K Hayashi T Oishi N Kubota D Kameya S Higasa K Genotype-phenotype correlations in RP1-associated retinal dystrophies: a multi-center cohort study in JAPAN J Clin Med 2021 10 2265 10.3390/jcm10112265 34073704
Mizobuchi K, Hayashi T, Oishi N, Kubota D, Kameya S, Higasa K, et al. Genotype-phenotype correlations in RP1-associated retinal dystrophies: a multi-center cohort study in JAPAN. J Clin Med. 2021;10:2265.34073704
80. Posey JE Harel T Liu P Rosenfeld JA James RA Coban Akdemir ZH Resolution of disease phenotypes resulting from multilocus genomic variation N Engl J Med 2017 376 21 31 10.1056/NEJMoa1516767 27959697
Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med. 2017;376:21–31.27959697
81. Huynh N Jeffrey BG Turriff A Sieving PA Cukras CA Sorting out co-occurrence of rare monogenic retinopathies: Stargardt disease co-existing with congenital stationary night blindness Ophthalmic Genet 2014 35 51 56 10.3109/13816810.2013.865762 24397708
Huynh N, Jeffrey BG, Turriff A, Sieving PA, Cukras CA. Sorting out co-occurrence of rare monogenic retinopathies: Stargardt disease co-existing with congenital stationary night blindness. Ophthalmic Genet. 2014;35:51–6.24397708
82. Lee W Schuerch K Xie Y Zernant J Tsang SH Simultaneous expression of ABCA4 and GPR143 mutations: a complex phenotypic manifestation Invest Ophthalmol Vis Sci 2016 57 3409 3415 10.1167/iovs.16-19621 27367509
Lee W, Schuerch K, Xie Y, Zernant J, Tsang SH, et al. Simultaneous expression of ABCA4 and GPR143 mutations: a complex phenotypic manifestation. Invest Ophthalmol Vis Sci. 2016;57:3409–15.27367509
83. Hayashi T Hosono K Kurata K Katagiri S Mizobuchi K Ueno S Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy Doc Ophthalmol 2020 140 147 157 10.1007/s10633-019-09727-1 31583501
Hayashi T, Hosono K, Kurata K, Katagiri S, Mizobuchi K, Ueno S, et al. Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy. Doc Ophthalmol. 2020;140:147–57.31583501
84. Dryja TP Hahn LB Reboul T Arnaud B Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness Nat Genet 1996 3 358 360 10.1038/ng0796-358
Dryja TP, Hahn LB, Reboul T, Arnaud B. Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet. 1996;3:358–60.
85. Sandberg MA Pawlyk BS Dan J Arnaud B Dryja TP Berson EL Rod and cone function in the Nougaret form of stationary night blindness Arch Ophthalmol 1998 116 867 872 10.1001/archopht.116.7.867 9682699
Sandberg MA, Pawlyk BS, Dan J, Arnaud B, Dryja TP, Berson EL. Rod and cone function in the Nougaret form of stationary night blindness. Arch Ophthalmol. 1998;116:867–72.9682699
86. Mashima Y Saga M Hiida Y Imamura Y Kudoh J Shimizu N Novel mutation in RP2 gene in two brothers with X-linked retinitis pigmentosa and mtDNA mutation of Leber hereditary optic neuropathy who showed marked differences in clinical severity Am J Ophthalmol 2000 130 357 359 10.1016/S0002-9394(00)00553-5 11020419
Mashima Y, Saga M, Hiida Y, Imamura Y, Kudoh J, Shimizu N. Novel mutation in RP2 gene in two brothers with X-linked retinitis pigmentosa and mtDNA mutation of Leber hereditary optic neuropathy who showed marked differences in clinical severity. Am J Ophthalmol. 2000;130:357–9.11020419
87. Multiple-system Atrophy Research Collaboration Mutations in COQ2 in familial and sporadic multiple-system atrophy N Engl J Med 2013 369 233 244 10.1056/NEJMoa1212115 23758206
Multiple-system Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013;369:233–44.23758206
88. Kurata K Hosono K Takayama M Katsuno M Saitsu H Ogata T Retinitis pigmentosa with optic neuropathy and COQ2 mutations: A case report Am J Ophthalmol Case Rep 2022 25 101298 10.1016/j.ajoc.2022.101298 35112026
Kurata K, Hosono K, Takayama M, Katsuno M, Saitsu H, Ogata T, et al. Retinitis pigmentosa with optic neuropathy and COQ2 mutations: A case report. Am J Ophthalmol Case Rep. 2022;25:101298.35112026
89. Stenton SL Sheremet NL Catarino CB Andreeva NA Assouline Z Barboni P Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy J Clin Invest 2021 131 e138267 10.1172/JCI138267 33465056
Stenton SL, Sheremet NL, Catarino CB, Andreeva NA, Assouline Z, Barboni P, et al. Impaired complex I repair causes recessive Leber’s hereditary optic neuropathy. J Clin Invest. 2021;131:e138267.33465056
90. Skorczyk-Werner A Tońska K Maciejczuk A Nowomiejska K Korwin M Ołdak M DNAJC30 gene variants are a frequent cause of a rare disease: Leber hereditary optic neuropathy in Polish patients Int J Mol Sci 2023 24 17496 10.3390/ijms242417496 38139324
Skorczyk-Werner A, Tońska K, Maciejczuk A, Nowomiejska K, Korwin M, Ołdak M, et al. DNAJC30 gene variants are a frequent cause of a rare disease: Leber hereditary optic neuropathy in Polish patients. Int J Mol Sci. 2023;24:17496.38139324
91. Imaizumi Y A recent survey of consanguineous marriages in Japan Clin Genet 1986 30 230 233 10.1111/j.1399-0004.1986.tb00600.x 3780039
Imaizumi Y. A recent survey of consanguineous marriages in Japan. Clin Genet. 1986;30:230–3.3780039
92. Nakanishi H Ohtsubo M Iwasaki S Hotta Y Mizuta K Mineta H Identification of 11 novel mutations in USH2A among Japanese patients with Usher syndrome type 2 Clin Genet 2009 76 383 391 10.1111/j.1399-0004.2009.01257.x 19737284
Nakanishi H, Ohtsubo M, Iwasaki S, Hotta Y, Mizuta K, Mineta H, et al. Identification of 11 novel mutations in USH2A among Japanese patients with Usher syndrome type 2. Clin Genet. 2009;76:383–91.19737284
93. Nakanishi H Ohtsubo M Iwasaki S Hotta Y Mizuta K Mineta H Hair roots as an mRNA source for mutation analysis of Usher syndrome-causing genes J Hum Genet 2010 55 701 703 10.1038/jhg.2010.83 20596040
Nakanishi H, Ohtsubo M, Iwasaki S, Hotta Y, Mizuta K, Mineta H, et al. Hair roots as an mRNA source for mutation analysis of Usher syndrome-causing genes. J Hum Genet. 2010;55:701–3.20596040
94. Nakanishi H Ohtsubo M Iwasaki S Hotta Y Takizawa Y Hosono K Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1 J Hum Genet 2010 55 796 800 10.1038/jhg.2010.115 20844544
Nakanishi H, Ohtsubo M, Iwasaki S, Hotta Y, Takizawa Y, Hosono K, et al. Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1. J Hum Genet. 2010;55:796–800.20844544
95. Nakanishi H Ohtsubo M Iwasaki S Hotta Y Usami S Mizuta K Novel USH2A mutations in Japanese Usher syndrome type 2 patients: marked differences in the mutation spectrum between the Japanese and other populations J Hum Genet 2011 56 484 490 10.1038/jhg.2011.45 21593743
Nakanishi H, Ohtsubo M, Iwasaki S, Hotta Y, Usami S, Mizuta K, et al. Novel USH2A mutations in Japanese Usher syndrome type 2 patients: marked differences in the mutation spectrum between the Japanese and other populations. J Hum Genet. 2011;56:484–90.21593743
96. Hayakawa M Fujiki K Kanai A Matsumura M Honda Y Sakaue H Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa Jpn J Ophthalmol 1997 41 1 6 10.1016/S0021-5155(96)00018-4 9147180
Hayakawa M, Fujiki K, Kanai A, Matsumura M, Honda Y, Sakaue H, et al. Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa. Jpn J Ophthalmol. 1997;41:1–6.9147180
97. Kurata K Hosono K Hayashi T Mizobuchi K Katagiri S Miyamichi D X-linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers Int J Mol Sci 2019 20 1518 10.3390/ijms20061518 30917587
Kurata K, Hosono K, Hayashi T, Mizobuchi K, Katagiri S, Miyamichi D, et al. X-linked retinitis pigmentosa in Japan: clinical and genetic findings in male patients and female carriers. Int J Mol Sci. 2019;20:1518.30917587
98. Wegscheider E Preising MN Lorenz B Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data Graefes Arch Clin Exp Ophthalmol 2004 242 501 511 10.1007/s00417-004-0891-1 15173948
Wegscheider E, Preising MN, Lorenz B. Fundus autofluorescence in carriers of X-linked recessive retinitis pigmentosa associated with mutations in RPGR, and correlation with electrophysiological and psychophysical data. Graefes Arch Clin Exp Ophthalmol. 2004;242:501–11.15173948
99. Ogino K Oishi M Oishi A Morooka S Sugahara M Gotoh N Radial fundus autofluorescence in the periphery in patients with X-linked retinitis pigmentosa Clin Ophthalmol 2015 9 1467 1474 10.2147/OPTH.S89371 26316687
Ogino K, Oishi M, Oishi A, Morooka S, Sugahara M, Gotoh N, et al. Radial fundus autofluorescence in the periphery in patients with X-linked retinitis pigmentosa. Clin Ophthalmol. 2015;9:1467–74.26316687
100. Hotta Y Inana G Gene transfer and expression of human ornithine aminotransferase Invest Ophthalmol Vis Sci 1989 30 1024 1031 2732018
Hotta Y, Inana G. Gene transfer and expression of human ornithine aminotransferase. Invest Ophthalmol Vis Sci. 1989;30:1024–31.2732018
101. Lipinski DM Thake M MacLaren RE Clinical applications of retinal gene therapy Prog Retin Eye Res 2013 32 22 47 10.1016/j.preteyeres.2012.09.001 22995954
Lipinski DM, Thake M, MacLaren RE. Clinical applications of retinal gene therapy. Prog Retin Eye Res. 2013;32:22–47.22995954
102. Daich Varela M Cabral de Guimaraes TA Georgiou M Michaelides M Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials Br J Ophthalmol 2022 106 445 451 10.1136/bjophthalmol-2020-318483 33712480
Daich Varela M, Cabral de Guimaraes TA, Georgiou M, Michaelides M. Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials. Br J Ophthalmol. 2022;106:445–51.33712480
103. Bainbridge JW Mehat MS Sundaram V Robbie SJ Barker SE Ripamonti C Long-term effect of gene therapy on Leber’s congenital amaurosis N Engl J Med 2015 372 1887 1897 10.1056/NEJMoa1414221 25938638
Bainbridge JW, Mehat MS, Sundaram V, Robbie SJ, Barker SE, Ripamonti C, et al. Long-term effect of gene therapy on Leber’s congenital amaurosis. N Engl J Med. 2015;372:1887–97.25938638
104. Jacobson SG Cideciyan AV Roman AJ Sumaroka A Schwartz SB Heon E Improvement and decline in vision with gene therapy in childhood blindness N Engl J Med 2015 372 1920 1926 10.1056/NEJMoa1412965 25936984
Jacobson SG, Cideciyan AV, Roman AJ, Sumaroka A, Schwartz SB, Heon E, et al. Improvement and decline in vision with gene therapy in childhood blindness. N Engl J Med. 2015;372:1920–6.25936984
105. Nakai H Yant SR Storm TA Fuess S Meuse L Kay MA Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo J Virol 2001 75 6969 6976 10.1128/JVI.75.15.6969-6976.2001 11435577
Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, Kay MA. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol. 2001;75:6969–76.11435577
106. Mendell JR Al-Zaidy S Shell R Arnold WD Rodino-Klapac LR Prior TW Single-dose gene-replacement therapy for spinal muscular atrophy N Engl J Med 2017 377 1713 1722 10.1056/NEJMoa1706198 29091557
Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713–22.29091557
107. Kurata K Hosono K Hotta Y Long-term clinical course in a patient with complete congenital stationary night blindness Case Rep Ophthalmol. 2017 8 237 244 10.1159/000462961 28512427
Kurata K, Hosono K, Hotta Y. Long-term clinical course in a patient with complete congenital stationary night blindness. Case Rep Ophthalmol. 2017;8:237–44.28512427
108. Kurata K Hosono K Hotta Y Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa Jpn J Ophthalmol 2018 62 186 193 10.1007/s10384-017-0560-7 29305715
Kurata K, Hosono K, Hotta Y. Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa. Jpn J Ophthalmol. 2018;62:186–93.29305715
109. Nishiguchi KM Ikeda Y Fujita K Kunikata H Akiho M Hashimoto K Phenotypic features of Oguchi disease and retinitis pigmentosa in patients with S-antigen mutations: a long-term follow-up study Ophthalmology 2019 126 1557 1566 10.1016/j.ophtha.2019.05.027 31257036
Nishiguchi KM, Ikeda Y, Fujita K, Kunikata H, Akiho M, Hashimoto K, et al. Phenotypic features of Oguchi disease and retinitis pigmentosa in patients with S-antigen mutations: a long-term follow-up study. Ophthalmology. 2019;126:1557–66.31257036
